CT scan study for pancreatic or liver bile cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how CT scans (detailed X-ray pictures) help diagnose pancreatic cancer or hepatobiliary (liver/bile duct) cancers. It may help your care team better decide what’s going on and plan next treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer or hepatobiliary cancer (hepatocellular carcinoma or intrahepatic cholangiocarcinoma)
- Your cancer is not “resectable” (it can’t be fully removed with surgery) and there is no distant spread (metastasis)
- Your cancer doctor has recommended chemotherapy for pancreatic cancer, or you’re being planned for definitive radiation for hepatobiliary cancer
- You must be well enough to do daily activities (ECOG performance status 0–1)
- You must be able to undergo CT scans with iodine contrast (and have no major heart problems or active severe infection)
- If you can get pregnant: you must use reliable birth control and not breastfeed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan drug (Ga-FAPI-46) to create clearer pictures of pancreatic and bile duct cancers. It may help doctors decide on the best next steps—especially before surgery—by checking tumor size and looking for spread.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This trial uses a special PET scan tracer to see how it spreads in the body for people newly diagnosed with pancreatic or head and neck cancer who haven't had treatment yet. It aims to help doctors better understand and potentially treat these cancers.
This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.
This study tests a new imaging procedure called LINFU® that may help doctors better detect pancreatic cancer. You may join if you have symptoms or an abnormal scan that suggests pancreatic cancer, and you're scheduled for a biopsy.
This study looks at how medical images and lab samples can predict which pancreatic cysts or tumors are more likely to be dangerous. If you are being evaluated for a pancreatic problem and haven’t started pancreas treatment, your scans and samples may help researchers improve risk prediction.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.